A multicentre analysis of Nocardia pneumonia in Spain: 2010-2016.

Int J Infect Dis

Biodonostia, Infectious Diseases Area, Respiratory Infection and Antimicrobial Resistance Group, Osakidetza Basque Health Service, Donostialdea Integrated Health Organisation, Microbiology Department, 20014 San Sebastian, Spain. Electronic address:

Published: January 2020

AI Article Synopsis

  • The study analyzed 55 cases of Nocardia pneumonia from 2010 to 2016 in five Spanish hospitals, revealing an average of six to nine cases annually.
  • Major underlying conditions included chronic obstructive pulmonary disease, bronchiectasis, and asthma, with many patients on corticosteroids, and a significant portion had neoplastic or hematological malignancies.
  • The one-year mortality rate was notably high at 38.2%, linked to the patients' existing pulmonary diseases, while most Nocardia species identified were susceptible to common antibiotics like linezolid.

Article Abstract

Objective: To analyse all cases of Nocardia pneumonia occurring between 2010 and 2016 in five Spanish hospitals.

Methods: This was a retrospective observational analysis of clinical and microbiological data collected from 55 cases of Nocardia pneumonia.

Results: There were one to 20 cases per hospital and six to nine cases per year. Chronic obstructive pulmonary disease, bronchiectasis, and asthma were the main predisposing underlying respiratory conditions. Thirty-four patients were receiving systemic and/or inhaled corticosteroids prior to infection, eight had neoplasia, and six had haematological malignancies. Clinical and radiological findings were common to pneumonia of other infectious aetiologies, except for the frequent presence of nodules and cavitation. Overall, the 1-year mortality was high (38.2%), and mortality was directly related to the pulmonary disease in 15 patients (27.3%). The most frequently identified species were N. cyriacigeorgica (n=21), N. abscessus (n=8), and N. farcinica (n=5). All Nocardia isolates were susceptible to linezolid and all but two were susceptible to amikacin and trimethoprim-sulfamethoxazole.

Conclusions: Nocardia pneumonia-associated mortality remains high, probably because of the debilitated status of patients in whom this pathogen is able to cause pulmonary infection.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijid.2019.10.032DOI Listing

Publication Analysis

Top Keywords

nocardia pneumonia
8
cases nocardia
8
pulmonary disease
8
nocardia
5
multicentre analysis
4
analysis nocardia
4
pneumonia spain
4
spain 2010-2016
4
2010-2016 objective
4
objective analyse
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!